Cargando…
Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
Fibroblasts reside in various organs and support tissue structure and homeostasis under physiological conditions. Phenotypic alterations of fibroblasts underlie the development of diverse pathological conditions, including organ fibrosis. Recent advances in single‐cell biology have revealed that fib...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360208/ https://www.ncbi.nlm.nih.gov/pubmed/33951198 http://dx.doi.org/10.1111/imr.12969 |
_version_ | 1783737701513560064 |
---|---|
author | Arai, Hiroyuki Sato, Yuki Yanagita, Motoko |
author_facet | Arai, Hiroyuki Sato, Yuki Yanagita, Motoko |
author_sort | Arai, Hiroyuki |
collection | PubMed |
description | Fibroblasts reside in various organs and support tissue structure and homeostasis under physiological conditions. Phenotypic alterations of fibroblasts underlie the development of diverse pathological conditions, including organ fibrosis. Recent advances in single‐cell biology have revealed that fibroblasts comprise heterogeneous subpopulations with distinct phenotypes, which exert both beneficial and detrimental effects on the host organs in a context‐dependent manner. In the kidney, phenotypic alterations of resident fibroblasts provoke common pathological conditions of chronic kidney disease (CKD), such as renal anemia and peritubular capillary loss. Additionally, in aged injured kidneys, fibroblasts provide functional and structural supports for tertiary lymphoid tissues (TLTs), which serve as the ectopic site of acquired immune reactions in various clinical contexts. TLTs are closely associated with aging and CKD progression, and the developmental stages of TLTs reflect the severity of renal injury. In this review, we describe the current understanding of fibroblast heterogeneity both under physiological and pathological conditions, with special emphasis on fibroblast contribution to TLT formation in the kidney. Dissecting the heterogeneous characteristics of fibroblasts will provide a promising therapeutic option for fibroblast‐related pathological conditions, including TLT formation. |
format | Online Article Text |
id | pubmed-8360208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83602082021-08-17 Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney Arai, Hiroyuki Sato, Yuki Yanagita, Motoko Immunol Rev Invited Reviews Fibroblasts reside in various organs and support tissue structure and homeostasis under physiological conditions. Phenotypic alterations of fibroblasts underlie the development of diverse pathological conditions, including organ fibrosis. Recent advances in single‐cell biology have revealed that fibroblasts comprise heterogeneous subpopulations with distinct phenotypes, which exert both beneficial and detrimental effects on the host organs in a context‐dependent manner. In the kidney, phenotypic alterations of resident fibroblasts provoke common pathological conditions of chronic kidney disease (CKD), such as renal anemia and peritubular capillary loss. Additionally, in aged injured kidneys, fibroblasts provide functional and structural supports for tertiary lymphoid tissues (TLTs), which serve as the ectopic site of acquired immune reactions in various clinical contexts. TLTs are closely associated with aging and CKD progression, and the developmental stages of TLTs reflect the severity of renal injury. In this review, we describe the current understanding of fibroblast heterogeneity both under physiological and pathological conditions, with special emphasis on fibroblast contribution to TLT formation in the kidney. Dissecting the heterogeneous characteristics of fibroblasts will provide a promising therapeutic option for fibroblast‐related pathological conditions, including TLT formation. John Wiley and Sons Inc. 2021-05-05 2021-07 /pmc/articles/PMC8360208/ /pubmed/33951198 http://dx.doi.org/10.1111/imr.12969 Text en © 2021 The Authors. Immunological Reviews published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Invited Reviews Arai, Hiroyuki Sato, Yuki Yanagita, Motoko Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney |
title | Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
|
title_full | Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
|
title_fullStr | Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
|
title_full_unstemmed | Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
|
title_short | Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
|
title_sort | fibroblast heterogeneity and tertiary lymphoid tissues in the kidney |
topic | Invited Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360208/ https://www.ncbi.nlm.nih.gov/pubmed/33951198 http://dx.doi.org/10.1111/imr.12969 |
work_keys_str_mv | AT araihiroyuki fibroblastheterogeneityandtertiarylymphoidtissuesinthekidney AT satoyuki fibroblastheterogeneityandtertiarylymphoidtissuesinthekidney AT yanagitamotoko fibroblastheterogeneityandtertiarylymphoidtissuesinthekidney |